Business Context and Reporting Period
This Form 8-K is a current report filed by MaxCyte, Inc. (Nasdaq: MXCT), a Delaware corporation, on March 23, 2026. The filing primarily addresses Item 5.02 regarding the appointment of a new Chief Financial Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and appointment details rather than operational financial performance.
Material Changes
The material change disclosed is the leadership transition in the finance department:
- Appointment: Parmeet Ahuja was appointed as Chief Financial Officer (CFO) and principal accounting officer, effective March 30, 2026.
- Succession: Mr. Ahuja succeeds Douglas Swirsky, who is transitioning out of the role as previously announced in November 2025.
- Background: Mr. Ahuja brings over 20 years of finance leadership experience, most recently serving as Vice President of Investor Relations at Agilent Technologies, Inc.
Compensation, Outlook, and Risks
Compensation Package:
- Base Salary: $450,000 annually.
- Performance Bonus: Target bonus of 50% of base salary.
- Equity Grants:
- Nonqualified stock option to purchase 375,000 shares.
- Restricted stock unit (RSU) award for 187,500 shares.
Severance Arrangements:
The Company expects to enter into a standard severance agreement. Key provisions include:
- Change in Control (within 12 months): Eligible for 12 months of base salary, 100% target bonus, 12 months of COBRA, and full acceleration of unvested equity if terminated without cause or resigning for good reason.
- Outside Change in Control Window: Eligible for 9 months of base salary and 9 months of COBRA under similar termination conditions.
Outlook and Risks: The filing text does not provide a clear value for future guidance, management commentary on business outlook, or specific risk factors beyond standard severance contingencies.
Investor Verification Checklist
- Verify the effective start date of Parmeet Ahuja as CFO (March 30, 2026).
- Confirm the total equity grant size (562,500 shares combined options and RSUs) and associated dilution impact.
- Review the specific definitions of "cause" and "good reason" in the pending severance agreement to understand termination triggers.
- Monitor subsequent filings for the departure details of the outgoing CFO, Douglas Swirsky.